Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianjiang Xueshuantong pill
- Development stage
- Unknown
- Lead developer
- Tianjiang Pharmaceutical
- Administration
- Oral
01
Overview
Tianjiang Xueshuantong pill is a Traditional Chinese Medicine (TCM) product manufactured by Jiangyin Tianjiang Pharmaceutical, primarily indicated for the treatment of cardiovascular and cerebrovascular diseases, including acute cerebral infarction (stroke). The formulation is based on the total saponins of *Panax notoginseng* (PNS), which include ginsenosides Rg1 and Rb1, and notoginsenoside R1. The drug functions by promoting blood circulation, resolving blood stasis, and improving microvascular perfusion. In clinical settings, it is often evaluated as an adjunctive therapy to standard thrombolytic agents like alteplase (rtPA) and human urinary kallindinogenase to enhance neurological recovery and reduce inflammatory markers such as C-reactive protein (CRP) and fibrinogen levels in patients following an ischemic event.
- Brand names
- Tianjiang Xueshuantong pill
- Other names
- Xueshuantong pillTianjiang XueshuantongXueshuantong WanTianjiang Xueshuantong Wan
02
Targets
FIIa/FXa (Coagulation factor II (Thrombin) and related coagulation proteases)PIEZO1 (Piezo-type mechanosensitive ion channel component 1)
Beyond the preview
Go deeper on Tianjiang Xueshuantong pill.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianjiang Xueshuantong pill.